Luke O'Connell

Luke O'Connell

Posts by Luke O'Connell

BPS Paper of the Year Awarded to Dr. Sumbria

April 23, 2024 by | School of Pharmacy

The Department of Biomedical and Pharmaceutical Sciences (BPS) has awarded Dr. Rachita Sumbria  the 2023 BPS Paper of the Year Award. Dr. Sumbria recognition is based on her publication, “Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.“ Dr. Sumbria’s groundbreaking research, conducted in collaboration with a

Patient Safety Conference Shapes Care for Third Consecutive Year

March 14, 2024 by | School of Pharmacy

Through a unique offering of education and collaboration, the 3rd Annual Pacific Coast Patient Safety Conference (PCPSC) brought together a record number of healthcare professionals for its 2024 conference in San Diego, California. Hosted as a boutique conference experience, the PCPSC attracted a diverse audience, including physicians, nurses, and pharmacists, seeking quality programming, networking, and

On the CUSP: February 2024

March 4, 2024 by | School of Pharmacy

Grants Dr. Keykavous Parang was awarded $3,420 for “Antibacterial Evaluation of Compounds Against Enterococcus faecalis (E. faecalis)” from Generdent, LLC, for a year-long trial. Awards and Recognitions Dr. Ajay Sharma has been invited to deliver a talk at a symposium on Ocular Graft versus Host Disease being held on March 8-9th at the School of

Dr. Cintia Citterio Receives Endocrine Society Early Investigator Award

February 20, 2024 by | School of Pharmacy

Dr. Cintia Citterio has been honored with the Endocrine Society Early Investigator Award, awarding her outstanding contributions to hormone-related research. Selected as one of five awardees nationwide, this recognition places her among the top emerging researchers for her role in addressing and advancing our understanding of hormone-related conditions. The Early Investigator Award supports the development

CUSP Advances in Genetic Editing with CRISPR Technology

February 14, 2024 by | School of Pharmacy

Offering new prospects for medical inventions, Chapman University School of Pharmacy researchers continue to make strides in gene editing. The recent study “Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery” centers around the manipulation of genetic material through the CRISPR technology, a technology that has regained momentum since initial reports in 2005. The authors, including faculty

Chapman Finds Unexpected Outcome in Pandemic-Related Opioid Challenges

February 9, 2024 by | School of Pharmacy

Dialing in on years 2018-2021, Chapman University faculty have begun to bridge the data gap in understanding data trends on how buprenorphine was prescribed to both insured and uninsured patients in California. Contrary to past findings that relied on data to insured patients, the study “Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic

NAPLEX Pass Rates Reach Second-Highest All-Time Scores

February 1, 2024 by | School of Pharmacy

CUSP is proud to announce a landmark achievement of its Doctor of Pharmacy Class of 2023, who have achieved historically high scores on the North American Pharmacist Licensure Examination (NAPLEX). The first-time pass rate for CUSP graduates reached 87.9%, placing CUSP graduates as the second-highest all-time pass rate in California.  These scores are also the

Log In
Open Main Menu